loading

Castle Biosciences Inc Aktie (CSTL) Neueste Nachrichten

pulisher
06:56 AM

Castle Biosciences, Revolution Medicines get FDA breakthrough statuses - MSN

06:56 AM
pulisher
05:15 AM

Leerink Partnrs Has Pessimistic View of CSTL Q2 Earnings - Defense World

05:15 AM
pulisher
Jul 23, 2025

What drives Castle Biosciences Inc. stock priceRapidly expanding wealth - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Castle Biosciences Inc. stockSkyrocketing investment returns - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Castle Biosciences stock jumps after FDA grants Breakthrough Device status to melanoma test - MSN

Jul 23, 2025
pulisher
Jul 23, 2025

Castle Bio, Revolution Medicines get FDA breakthrough statuses - Seeking Alpha

Jul 23, 2025
pulisher
Jul 23, 2025

Castle Biosciences stock jumps after FDA grants Breakthrough Device status - Investing.com India

Jul 23, 2025
pulisher
Jul 23, 2025

FDA Grants Breakthrough Status to Melanoma Test - Conexiant

Jul 23, 2025
pulisher
Jul 23, 2025

FDA grants breakthrough device status to Castle Biosciences’ melanoma test - Investing.com Australia

Jul 23, 2025
pulisher
Jul 23, 2025

FDA Grants Breakthrough Device Designation to Castle Biosciences’ DecisionDx®-Melanoma Test - GlobeNewswire

Jul 23, 2025
pulisher
Jul 23, 2025

New York State Common Retirement Fund Has $3.27 Million Stock Position in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jul 23, 2025
pulisher
Jul 22, 2025

Is Castle Biosciences Inc. a good long term investmentHigh-margin investment plays - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Castle Biosciences Inc. Stock Analysis and ForecastTremendous financial leverage - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Teacher Retirement System of Texas Grows Position in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jul 21, 2025
pulisher
Jul 21, 2025

Stephens Inc. AR Has $273,000 Stake in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jul 21, 2025
pulisher
Jul 17, 2025

Castle Biosciences Achieves Multiple Awards Recognizing Workplace Excellence in 2025 Top Workplaces Program - Quiver Quantitative

Jul 17, 2025
pulisher
Jul 17, 2025

Castle Biosciences earns multiple Top Workplaces awards, including national Healthcare Industry award. - AInvest

Jul 17, 2025
pulisher
Jul 17, 2025

Castle Biosciences Honored with Multiple Top Workplaces Awards Recognizing the Company’s Strong Culture - GlobeNewswire

Jul 17, 2025
pulisher
Jul 17, 2025

Castle Biosciences Dominates Healthcare Workplace Rankings with 7 Major Awards and #3 Industry Position - Stock Titan

Jul 17, 2025
pulisher
Jul 16, 2025

How Castle Biosciences Inc. stock performs during market volatilityTop Rated Trade Entries - Newser

Jul 16, 2025
pulisher
Jul 16, 2025

Castle Biosciences, Inc. (NASDAQ:CSTL) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Jul 16, 2025
pulisher
Jul 16, 2025

Castle Biosciences to Release Q2 2025 Financial Results and Host Conference Call on Aug. 4 - AInvest

Jul 16, 2025
pulisher
Jul 15, 2025

Why Castle Biosciences Inc. stock attracts strong analyst attentionEarly Buy Suggestion - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Castle Biosciences Inc. stock price move sharplyProven Trading Plan - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Castle Biosciences' Q2 Results: Diagnostic Innovation Fuels Growth Amid Profit Challenges - AInvest

Jul 14, 2025
pulisher
Jul 14, 2025

Castle Biosciences, Inc. to Release Second Quarter Financial Results on August 4, 2025 - Nasdaq

Jul 14, 2025
pulisher
Jul 14, 2025

Castle Biosciences to Release Second Quarter 2025 Financial - GlobeNewswire

Jul 14, 2025
pulisher
Jul 14, 2025

Castle Biosciences Sets Q2 2025 Earnings Date: Key Financial Results Coming August 4 - Stock Titan

Jul 14, 2025
pulisher
Jul 07, 2025

Allspring Global Investments Holdings LLC Raises Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jul 07, 2025
pulisher
Jun 30, 2025

Castle Biosciences, Inc.(NasdaqGM: CSTL) dropped from Russell 2500 Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 28, 2025

Is Castle Biosciences (NASDAQ:CSTL) Using Too Much Debt? - 富途牛牛

Jun 28, 2025
pulisher
Jun 25, 2025

GAMMA Investing LLC Purchases 4,142 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jun 25, 2025
pulisher
Jun 25, 2025

Castle Biosciences partners with SciBase for diagnostic tests - MSN

Jun 25, 2025
pulisher
Jun 19, 2025

Castle Biosciences Awards Major RSU Package: 135,978 Shares with 4-Year Vesting for Employee Retention - Stock Titan

Jun 19, 2025
pulisher
Jun 17, 2025

Castle Biosciences Inc (CSTL) Stock Price Down 4.54% on Jun 17 - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Castle Biosciences partners with SciBase to develop atopic dermatitis test - Investing.com India

Jun 17, 2025
pulisher
Jun 16, 2025

Castle Biosciences, SciBase Partner to Develop Predictive Tests for Skin Conditions - marketscreener.com

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences partners with SciBase for diagnostic tests (CSTL) - Seeking Alpha

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences partners with SciBase to develop atopic dermatitis test By Investing.com - Investing.com Nigeria

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences (CSTL) Partners with SciBase for Dermatology Advancements | CSTL Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences enters collaboration, license agreement with Scibase to develop diagnostic tests for dermatologic diseases - MarketScreener

Jun 16, 2025
pulisher
Jun 16, 2025

SciBase resolves on a directed share issue of SEK 19 million and announces its intention to carry out an additional directed share issue of approximately SEK 11 million - Yahoo Finance

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences Enters Collaboration and License Agreement wi - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

SciBase signs license agreement with Castle Biosciences to develop dermatology diagnostic tests - marketscreener.com

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences Enters Collaboration and License Agreement with SciBase to Develop Diagnostic Tests for Dermatologic Diseases - The Manila Times

Jun 16, 2025
diagnostics_research WAT
$298.65
price up icon 0.94%
$139.84
price up icon 1.34%
diagnostics_research DGX
$172.58
price up icon 1.18%
diagnostics_research LH
$269.08
price up icon 7.40%
diagnostics_research MTD
$1,259.72
price up icon 0.27%
diagnostics_research A
$120.21
price up icon 0.59%
Kapitalisierung:     |  Volumen (24h):